| Serial Number | 76113588 |
| Word Mark | TRUPRIMATE |
| Filing Date | Wednesday, August 16, 2000 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, January 24, 2009 |
| Registration Number | 2561384 |
| Registration Date | Tuesday, April 16, 2002 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 22, 2002 |
| Goods and Services | Describing and providing scientific and medical research services involving simian genetic material and models for testing pharmaceuticals, treatments, and human respiratory diseases, including symptoms such as bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms, particularly marmosets for use in testing preventative and therapeutic treatments for respiratory, airway and pulmonary diseases, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure associated with ischemia as well as the administration of certain drugs, side effects associated with adenosine administration such as when treating SupraVentricular Tachycardia (SVT) and in adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers such as leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, January 24, 2009 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, November 30, 1996 |
| First Use In Commerce Date | Saturday, May 31, 1997 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Saturday, January 24, 2009 | CANCELLED SEC. 8 (6-YR) |
| Friday, May 18, 2007 | CASE FILE IN TICRS |
| Tuesday, April 16, 2002 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 22, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 2, 2002 | NOTICE OF PUBLICATION |
| Thursday, October 25, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 10, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 7, 2001 | NON-FINAL ACTION MAILED |
| Thursday, February 1, 2001 | ASSIGNED TO EXAMINER |
| Wednesday, January 31, 2001 | ASSIGNED TO EXAMINER |